Mark Kozloff to Chemotherapy-Induced Febrile Neutropenia
This is a "connection" page, showing publications Mark Kozloff has written about Chemotherapy-Induced Febrile Neutropenia.
Connection Strength
0.041
-
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. Ann Oncol. 2018 09 01; 29(9):1932-1938.
Score: 0.041
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.